Novo Nordisk Investigational Site
Plainsboro, New Jersey, 08536, United States
NCT Number: NCT03430154
An online web-based cross-sectional survey in which participants will complete a distinct questionnaire for patients with hemophilia and obesity (PwHO) and/or their carers/spouses/partners, or a distinct questionnaire for healthcare professionals. Each questionnaire consists of more than 100 items including pre-coded (multiple choice) closed-ended questions, yes/no questions and rating scales. It is estimated that this one-off survey will take approximately 45-60 minutes to complete.
As a cross-sectional study, there will be no treatment of patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Plainsboro, New Jersey, 08536, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No treatment given
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Time frame: Start of interviews day 1 until end of data collection day 90
Data is collected via online questionnaires
Novo Nordisk A/S
Industry
Acronym: ACTION to HOPE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02199717
Behavior, Blood Coagulation Disorders
Toronto, Ontario, Canada
View Trial DetailsNCT07691437
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Trabzon, Turkey (Türkiye)
View Trial DetailsNCT03569891
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Phoenix, Arizona, United States
View Trial DetailsNCT03587116
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Palo Alto, California, United States
View Trial Details